QA: Mirati Therapeutics Inc in us_pharma/2020

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001576263_2021_Mirati_Therapeutics_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001576263, Mirati Therapeutics Inc

  xvar xval
0 AssetsCurrent 1,403,643,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 7,809,000
3 remainder_Assets 64,676,000
4 LiabilitiesCurrent 71,472,000
5 LiabilitiesNoncurrent 43,867,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 287,503,685
9 ResearchAndDevelopmentExpense 881,209,560
10 remainder_Expenses 0
11 remainder_Revenues 6,705,359
12 remainder_NetIncome 18,348,972
13 remainder_ComprehensiveNetIncome 408,442
  yvar yval
0 Assets 1,476,128,000
1 Liabilities 115,339,000
2 Expenses 1,168,713,245
3 Revenues 6,705,359
4 StockholdersEquity 1,360,789,000
5 NetIncome -1,143,658,914
6 ComprehensiveNetIncome -1,143,454,693
7 BaseVar 1,392,821,509
8 EconomicCapitalRatiobeforeLimitedLiability 2.29
9 EconomicCapitalRatio 3.22

Edgar->Model Mapping

Feature Distribution

Change over Time